We're maintaining the world's largest resposity of hair loss
research. You can help out the community by
sending a PDF of this study here
.
Not sure how to get a study's PDF? You can email the authors
of the study.
Minoxidil may inhibit androgen receptors and affect hormonal pathways, potentially explaining its effectiveness in treating androgeneticalopecia (AGA). Users discuss its varying effectiveness on scalp versus facial hair and note fewer side effects with topical use compared to oral.
A person in their early 30s has been using finasteride for about 10 years and recently started oralminoxidil, vitamin chewables, and dermarolling to address hair loss. They noticed pigmented vellus hairs and potential regrowth, questioning if oralminoxidil is more effective than topical due to enzyme differences.
A 31-year-old male experienced significant hair regrowth on his crown after using oralminoxidil (initially 1.25 mg, increased to 2.5 mg, then reduced back to 1.25 mg) and finasteride (1 mg), without side effects except increased hair on arms, beard, and eyelashes. He also used anaphase conditioner and shampoo but no derma rolling or additional multivitamins.
The user is treating hair loss with topical Minoxidil, Finasteride, RU58841, microneedling, and Ketoconazole. For grey hair, they use L-Cysteine, L-Methionine, and PABA, and have noticed some re-pigmentation.
The user experienced significant hair regrowth using topical Minoxidil and oral Finasteride over five months, with darker and thicker hair and new follicles appearing. They are considering waiting 1-2 years before deciding on a hair transplant, as further improvement is expected.
The user has been using a hair loss treatment regimen including Minokem N, topical finasteride+minoxidil, and oralminoxidil for three months and has seen progress. However, they've also noticed an increase in grey hair, particularly on the sides of their head, and are seeking advice.